UA87838C2 - Stabilised supersaturated solids of lipophilic drugs - Google Patents

Stabilised supersaturated solids of lipophilic drugs

Info

Publication number
UA87838C2
UA87838C2 UAA200610356A UAA200610356A UA87838C2 UA 87838 C2 UA87838 C2 UA 87838C2 UA A200610356 A UAA200610356 A UA A200610356A UA A200610356 A UAA200610356 A UA A200610356A UA 87838 C2 UA87838 C2 UA 87838C2
Authority
UA
Ukraine
Prior art keywords
lipophilic
lipophilic drugs
silica dioxide
improved dissolution
solids
Prior art date
Application number
UAA200610356A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Адриан Функе
Торстен Вагнер
Ральф Липп
Original Assignee
Байер Шеринг Фарма Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Шеринг Фарма Акциенгезельшафт filed Critical Байер Шеринг Фарма Акциенгезельшафт
Publication of UA87838C2 publication Critical patent/UA87838C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a pharmaceutical composition with improved dissolution of lipophilic drugs in an aqueous medium. It is found that pharmaceutical compositions comprising a powder of lipophilic compounds, such as hormones and steroids (e.g. drospirenone and estradiol valerale) in molecularly dispersed form together with a carrier having a specific surface area of at least 250m/g such as silica dioxide, e.g. silica dioxide marketed under the name Aeroperl®, has improved dissolution properties of the lipophilic drug.
UAA200610356A 2004-03-10 2005-03-10 Stabilised supersaturated solids of lipophilic drugs UA87838C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55133004P 2004-03-10 2004-03-10

Publications (1)

Publication Number Publication Date
UA87838C2 true UA87838C2 (en) 2009-08-25

Family

ID=50633856

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200610356A UA87838C2 (en) 2004-03-10 2005-03-10 Stabilised supersaturated solids of lipophilic drugs

Country Status (1)

Country Link
UA (1) UA87838C2 (en)

Similar Documents

Publication Publication Date Title
TW200600116A (en) Stabilised supersaturated solids of lipophilic drugs
PT1748756E (en) Compositions comprising drospirenone molecularly dispersed
WO2007027941A3 (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
EP1624855A4 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EE200300109A (en) Process for the preparation of a liquid emulsion composition and emulsion concentrate, pharmaceutical composition, emulsion concentrate, kit and emulsion composition
WO2006039022A3 (en) Controlled regional oral delivery
TW200744677A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
BR0215380A (en) Pharmaceutical or nutraceutical micronized powder for immediate release and use thereof
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP2127642A3 (en) Microemulsions as solid dosage forms for oral administration
IL164217A0 (en) Pharmaceutical compositions containing water-soluble propofol and methods of administering same
EA200701923A1 (en) DRUG FORM FOR THE ORAL ADMINISTRATION OF VITAMIN
WO2003035034A3 (en) Powder for nasal administration of drugs
MXPA05002337A (en) Water stabilized medicinal aerosol formulation related applications.
WO2004030649A3 (en) Methods for producing and stabilising microsuspensions and nanosuspensions by means of amphiphiles and polyelectrolytes
HK1120417A1 (en) Stable nanoparticle formulations
UA87838C2 (en) Stabilised supersaturated solids of lipophilic drugs
MD2722B2 (en) Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosis
DE602006004365D1 (en) SOLID ORAL PHARMACEUTICAL FORM OF THE TRIBULIN INGREDIENT INDIBULIN
WO2001022943A8 (en) A slow release pharmaceutical composition comprising a magnesium oxychloride cement
MY120392A (en) A novel drug delivery system : formulation for fat-soluble drugs
CY1109564T1 (en) CONSOLIDATED SUPPLIED SUPPLIES OF Fatty Medicines
TW200609000A (en) Molecular dispersions of drospirenone
TH75689A (en) Super-saturated lipophilic stabilized solids
WO2006021709A3 (en) Anhydrous solid particle containing a lipid composition and pharmaceutical composition containing said particles